Compound C Protects Mice from HFD-Induced Obesity and Nonalcoholic Fatty Liver Disease
Objectives. The aim of this study was to investigate the effects of compound C on an in vivo mouse model of high-fat diet- (HFD-) induced obesity and hepatosteatosis. Methods. C57BL/6 mice were fed with a standard diet (n = 5) for 16 weeks and then injected saline once a day for 4 weeks as the norma...
Main Authors: | Fang Wang, Yuxing Liu, Jingjing Yuan, Wenjun Yang, Zhaohui Mo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2019/3206587 |
Similar Items
-
Fermented Rhus Verniciflua Stokes Extract Alleviates Nonalcoholic Fatty Liver through the AMPK/SREBP1/PCSK9 Pathway in HFD-Induced Nonalcoholic Fatty Liver Animal Model
by: Seon-Ok Lee, et al.
Published: (2020-09-01) -
Alcoholic liver disease with nonalcoholic fatty liver disease and obesity
by: CAO Haixia
Published: (2019-03-01) -
Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice
by: Lan N. Tu, et al.
Published: (2017-07-01) -
Obesity and nonalcoholic fatty liver disease: current perspectives
by: Sarwar R, et al.
Published: (2018-09-01) -
Nonalcoholic Fatty Liver Disease in Severely Obese Patients
by: Chi-Ming Tai, et al.
Published: (2015)